This is the study that I read:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088823/
The part about infections comes from having family members of patients take IVM and other families not, the difference in the amount of family members getting symptoms was getting close to 90%
That would be my best guess on where these people are getting that.
Extract:
Shouman conducted an RCT at Zagazig University in Egypt, including 340 (228 treated and 112 control) family members of patients positive for SARS-CoV-2 through PCR.44 Ivermectin (approximately 0.25 mg/kg) was administered twice, on the day of the positive test and 72 hours later. After a two-week follow-up, a large and statistically significant decrease in COVID-19 symptoms among household members treated with ivermectin was found, 7.4% versus 58.4%, P < 0.001.
This is the study that I read: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088823/ The part about infections comes from having family members of patients take IVM and other families not, the difference in the amount of family members getting symptoms was getting close to 90% That would be my best guess on where these people are getting that.
Extract: Shouman conducted an RCT at Zagazig University in Egypt, including 340 (228 treated and 112 control) family members of patients positive for SARS-CoV-2 through PCR.44 Ivermectin (approximately 0.25 mg/kg) was administered twice, on the day of the positive test and 72 hours later. After a two-week follow-up, a large and statistically significant decrease in COVID-19 symptoms among household members treated with ivermectin was found, 7.4% versus 58.4%, P < 0.001.